All terms in NCIT
| Label | Id | Description |
|---|---|---|
| Stage I Cervical Cancer AJCC v8 | NCIT_C139734 | [Stage I includes: T1, Any N, M0. T1: Tumor confined to uterus (extension to corpus should be disregarded). M0: No distant metastasis. (AJCC 8th Ed.)] |
| Stage IB1 Cervical Cancer AJCC v8 | NCIT_C139739 | [Stage IB1 includes: T1b1, Any N, M0. T1b1: Tumor with clinically visible lesion 4.0 cm or less in greatest dimension. M0: No distant metastasis. (AJCC 8th Ed.)] |
| Cervical Cancer by AJCC v8 Stage | NCIT_C139733 | [A term that refers to the staging of cervical cancer according to the American Joint Committee on Cancer, 8th edition.] |
| Stage IA1 Cervical Cancer AJCC v8 | NCIT_C139736 | [Stage IA1 includes: T1a1, Any N, M0. T1a1: Invasive cervical carcinoma with measured stromal invasion of 3.0 mm or less in depth and 7.0 mm or less in horizontal spread. M0: No distant metastasis. (AJCC 8th Ed.)] |
| Trace Dosing Unit | NCIT_C48547 | [An extremely small amount.] |
| Troche Dosing Unit | NCIT_C48548 | [A dosing unit equal to the amount of active ingredient(s) contained in a troche.] |
| Autologous ACTR-CD16-CD28-expressing T-lymphocytes ACTR707 | NCIT_C139730 | [A preparation of autologous T-lymphocytes that have been genetically modified, using proprietary Antibody-Coupled T-cell Receptor (ACTR) technology, to express a chimeric protein containing, at least, the extracellular Fc receptor domain of CD16, normally found on certain immune cells, such as natural killer (NK) cells, coupled to the co-stimulatory signaling domain of CD28, with potential immunostimulating and antineoplastic activities. Upon reintroduction into the patient with co-administration of a cancer-specific antibody, the co-administered antibody targets and binds to the tumor-associated antigen (TAA) expressed on the tumor cell. In turn, the autologous ACTR-CD16-CD28-expressing T-lymphocytes ACTR707 bind to the antibody, become activated and induce the destruction of the tumor cells by a) releasing cytotoxins that directly kill cancer cells; b) releasing cytokines that trigger an immune response and recruit other immune-mediated killer cells to kill the tumor cells; c) targeting and killing adjacent tumor cells that are not bound to the antibody; d) inducing T-cell proliferation and thereby further enhancing the T-cell mediated tumor cell attack. Compared to other T-cell products, ACTR-based products do not target a specific TAA and can potentially be used in a variety of tumors because targeting is based on the specificity of the co-administered antibody.] |
| Tube Dosing Unit | NCIT_C48549 | [A dosing unit equal to the amount of active ingredient(s) contained in a tube.] |
| EWSR1/ZNF444 Fusion Gene | NCIT_C139731 | [A fusion gene that results from a chromosomal translocation t(19;22)(q13;q12) which fuses exon 8 of the EWSR1 gene to exon 5 of the ZNF444 gene. This fusion may be associated with myoepithelioma.] |
| EWSR1/ZNF444 Fusion Protein | NCIT_C139732 | [A fusion protein encoded by the EWSR1/ZNF444 fusion gene. This protein is comprised of the transactivation domain of the RNA-binding protein EWS fused to the last six C-terminal amino acids of zinc finger protein 444.] |
| Orgasm | NCIT_C73521 | [The height of sexual excitement, consisting of a series of involuntary contractions of the muscles of the genitals, lower pelvis, and anus, accompanied by strong feelings of pleasure.] |
| Normal, Unit of Concentration | NCIT_C48554 | [A unit of concentration equal to one gram-equivalent of solute per one liter of solution.] |
| Normality Unit | NCIT_C64569 | [A concentration unit measured as the number gram equivalents of solute per liter of solution.] |
| Sexual Arousal | NCIT_C73522 | [Heightened urges of sexual desires in preparation for sexual behavior.] |
| Mole per Liter | NCIT_C48555 | [A unit of concentration (molarity unit) equal to one mole of solute per one liter of solution.] |
| Hydnocarpus kurzii Seed Oil | NCIT_C73523 | [The oil pressed from the seeds of the Chaulmoogra tree. Hydnocarpus seed oil is used for its antibacterial properties in the treatment of leprosy and other skin conditions.] |
| Structured Product Labeling Color | NCIT_C48556 | |
| Celery Seed Oil | NCIT_C73524 | [The oil extracted from the seeds of Apium graveolens. Celery seed oil is used to treat disorders of the digestive system.] |
| Structured Product Labeling Shape | NCIT_C48557 | |
| Vial Dosing Unit | NCIT_C48551 | [A dosing unit equal to the amount of active ingredient(s) contained in a single vial.] |